Hygea VCT plc Scancell to present at Biotech Capital
24 2월 2016 - 7:42PM
RNS Non-Regulatory
TIDMHYG
Hygea VCT plc
24 February 2016
For immediate release 24 February 2016
Hygea vct plc
Scancell plc to present at Biotech Capital in London on 3rd
March 2016
The Board of Hygea vct plc announces that Hygea's largest
investment by value, Scancell plc (www.scancell.co.uk), is
presenting at the Biotech Capital Conference being held in London
on 3rd March 2016. Attendance is free, with registration via
www.biotech-capital.com/conferences - a recording of the event will
be posted on the website. An article Immunotherapy: a turning point
in cancer treatment by Vadim Alexandre can be found on page 8 of
the AIM Journal
(http://www.hubinvest.com/AIMPDFFebruary2016_77.pdf).
Enquiries: Charles Breese, director on 01280 703482
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAUSSRRNAAUUAR
(END) Dow Jones Newswires
February 24, 2016 05:42 ET (10:42 GMT)
Bioscience Vct (LSE:BVP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Bioscience Vct (LSE:BVP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
